Cyclerion Therapeutics Inc. (CYCN) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Cyclerion Therapeutics (CYCN) qon-miya to'sig'ini yengib o'tish asosiy muvaffaqiyat omili bo'lgan miya patologiyalarini davolash uchun eruvchan guanilat siklaza aktivatorlarini ishlab chiqishga e'tibor qaratadi. GURU.Markets platformasidagi ushbu narxlar grafigi aktivning dinamikasini tasdiqlaydi, separate_debt_long_eq ko'rsatkichi esa 0.00 darajasida turibdi. Cyclerion Therapeutics (CYCN) noyob tashxislarida neyron aloqalarini tuzatish uchun ilg'or usullarni joriy qilmoqda, ammo likvidlikning yetishmasligi va FDA ning qat'iy nazorati uning yuqori ixtisoslashgan ekotizimini kengaytirishni cheklaydi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_CYCN_-_Cyclerion-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "CYCN - Cyclerion Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 09.09.2026 oraligʻida | 👁️GURU.Markets👁️")
Cyclerion Therapeutics Inc. (CYCN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Cyclerion Therapeutics|CYCN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Cyclerion|CYCN - Kompaniyaning umumiy qarzi|Balans qiymatiga qarzlar Cyclerion Therapeutics, Inc.|CYCN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Cyclerion Therapeutics|Tezkor likvidlik cyclerion.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:CYCN (cyclerion.com)
Cyclerion Therapeutics kompaniyasining raqobatlashish qobiliyati uning R&D strategiyasini o'zgartirish davridagi kapital boshqaruvining samaradorligiga bog'liq. Uzoq muddatli kreditlarning kapitalga nisbatini tahlil qilish orqali investor moliyaviy leveraj darajasini va tashqi qarzga bo'lgan bog'liqlikni baholaydi. Ushbu ko'rsatkich foiz stavkalari risklariga chidamlilikni aniqlash uchun bir yildan ortiq muddatli majburiyatlarni sof aktivlar bilan solishtiradi. Kichik molekulyar litsenziyalashga o'tayotgan kompaniya uchun past nisbat resurslarning saqlanib qolganini tasdiqlaydi. Bozor cheklangan pul oqimi sharoitida me'yordagi qarzni defoltga qarshi himoya vositasi deb hisoblaydi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning o'z kapitaliga nisbati BHVN (Biohaven)|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|PRAX - Uzoq muddatli qarzning o'z kapitaliga nisbati|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|CBLL: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|OMER: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzdorlikning kapitalga nisbati acimmune.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN (Tevogen Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|SAVA (Cassava Sciences Inc) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRVO (CervoMed, Inc.)|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Clene (CLNN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PepGen Inc|jupiterneurosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|ANVS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Firefly Neuro AIFF|KLTO: Uzoq muddatli qarzning o'z kapitaliga nisbati|NeuroSense Therapeutics - Uzoq muddatli kreditlarning kapitalga nisbati|RVPH: Uzoq muddatli qarzning kapitalga nisbati|MTVA - Uzoq muddatli qarzdorlikning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies Inc. (HSDT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|Uzoq muddatli qarzdorlikning kapitalga nisbati bionomics.com.au|Uzoq muddatli qarzning kapitalga nisbati NERV (Minerva Neurosciences, Inc.)|ATHA - Uzoq muddatli qarzning o'z kapitaliga nisbati|ADXN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alzamend Neuro, Inc.|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp.|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati